Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Le Bonheur Children's Hospital
With
The Campbell Foundation
For this study, participants will be randomized (randomly assigned) to either receive scheduled acetaminophen-hydrocodone (which is the current standard of care treatment) or acetaminophen and ibuprofen (the experimental treatment) for post operative pain control following surgery for supracondylar humerus fracture. Patients in the experimental treatment group who require 2 doses of breakthrough pain medication in a row in order to control their pain will be switched to the standard of care treatment. Follow up information regarding outcomes post-discharge will be collected via secure email or text 48-72 hours post-discharge.
Age
4–13
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
isolated supracondylar humerus fracture
undergoing closed reduction with percutaneous pinning (CRPP)
You may not be if
Allergies to acetaminophen, ibuprofen, and/or acetaminophen-HYDROcodone
Liver or renal disease
history of bleeding disorder
medical diagnosis of juvenile arthritis
on chronic NSAIDs or Opioids PRIOR to the procedure
medical diagnosis of coagulopathies, open fractures, other injuries at time of diagnosis (multi-system trauma)
vascular compromise and/or compartment syndrome upon admission
Clareo Health | NSAIDs vs Opioids for Post-op Pain in Supracondylar Humerus Fractures
